The group shares litigation developments and discusses strategy, in this emerging litigation.Join the Litigation Group
Tepezza Litigation Group
Tepezza was approved in 2020 for the treatment of thyroid eye disease. Unfortunately, it is repeatedly associated with hearing loss, tinnitus with hearing damage, and permanent hearing damage. The group shares litigation developments and discusses strategy, in this emerging litigation.
The Tepezza Litigation Group was formed at the 2023 Winter Convention. Members have access to a document library and list server. The Group meets at AAJ Annual and Winter conventions and plans to host programs and meetings throughout the year.
Dues: $150 per member annually
Stacy Hauer | Johnson Becker, PLLC, St. Paul, MN
Molly Wells | Wallace Miller, Chicago, IL